Viewing Study NCT07123415

Bugs

Ignite Creation Date: 2025-12-18 @ 8:24 AM

Ignite Modification Date: 2025-12-18 @ 8:24 AM

Study NCT ID: NCT07123415

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module